immune design corp
(IMDZ:Consolidated Issue listed on NASDAQ Global Market)
Bruce L. A. Carter Ph.D.
|Age||Total Calculated Compensation||This person is connected to 194 board members in 11 different organizations across 17 different industries.|
See Board Relationships
Dr. Bruce L. A. Carter, Ph.D., served as the Chief Executive Officer at ZymoGenetics Inc., from April 1998 to January 2009. Dr. Carter served as President of ZymoGenetics from 1998 to July 2, 2007 and from 1988 to 1995. He led the negotiations that established ZymoGenetics as an independent company from Novo Nordisk in 2000. He served as a Lecturer of Trinity College, University of Dublin from 1975 to 1982. He has over 25 years of pharmaceutical experience. From 1994 ...
1616 Eastlake Avenue EastPhone: 206-682-0645
Seattle, Washington 98102
Board Members Memberships*
Member of the Board of Directors
Director and Member of Nominating & Governance Committee
Independent Director, Chairman of Science, Technology & Operations Committee and Member of Risk Management Committee
Chairman of The Board, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Director, Chairman of Compensation Committee and Member of Audit Committee
Independent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Queen Elizabeth College, University Of London
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|There is no Competitor Compensation data available.|